Not applicableUnknownNCT04320303What this trial is testingCMV Infection and Immune Intervention After TransplantationWho this might be right forCMV ViremiaTransplantation Infection Peking University People's Hospital 30
Testing effectiveness (Phase 2)Study completedNCT01646645What this trial is testingPrimary Transplant Donor Derived CMVpp65 Specific T-cells for The Treatment of CMV Infection or Persistent CMV Viremia After Allogeneic Hematopoietic Stem Cell TransplantationWho this might be right forCytomegalovirus Memorial Sloan Kettering Cancer Center 58
Testing effectiveness (Phase 2)Study completedNCT00285259What this trial is testingCytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)Who this might be right forAcute Lymphoblastic LeukemiaChronic Myelogenous LeukemiaAcute Myelogenous Leukemia+3 more Astellas Pharma Inc 112
Testing effectiveness (Phase 2)Looking for participantsNCT06574789What this trial is testingIndividualised Dose Optimisation of Ganciclovir in Immunocompromised Children Trial (ID-MAGIC)Who this might be right forCytomegalovirus Viraemia Murdoch Childrens Research Institute 232
Not applicableStudy completedNCT02370758What this trial is testingCell Mediated Immunity for Secondary Prophylaxis in CMV SOT PatientsWho this might be right forCytomegalovirus Viraemia University Health Network, Toronto 32
Large-scale testing (Phase 3)Study completedNCT00006145What this trial is testingPreventing Cytomegalovirus (CMV) Organ Damage With Valganciclovir in People With HIVWho this might be right forCytomegalovirus InfectionsHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 350
Testing effectiveness (Phase 2)Study completedNCT01329185What this trial is testingTreating Kidney Donors With Valganciclovir to Reduce Viral Transmission to RecipientsWho this might be right forEBV ViremiaCMV Viremia University of Minnesota 17
Not applicableActive Not RecruitingNCT07015801What this trial is testingCMV-specific Donor-derived T Lymphocytes for the Treatment of Recalcitrant CMV Infection in a Patient With Primary ImmunodeficiencyWho this might be right forCytomegalovirus ViremiaCytomegalovirus PneumoniaT-Lymphocyte Immunodeficiency University of Calgary 1
Not applicableStudy completedNCT04478474What this trial is testingCytomegalovirus (CMV) Viremia and Disease Occurrence in Pediatric Allogeneic Stem Cell Transplantation RecipientsWho this might be right forCytomegalovirus Infections New York Medical College 100
Testing effectiveness (Phase 2)Looking for participantsNCT06059391What this trial is testingCMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell TransplantWho this might be right forAcute Lymphoblastic LeukemiaAcute Myeloid LeukemiaChronic Lymphocytic Leukemia+7 more City of Hope Medical Center 216
Testing effectiveness (Phase 2)Study completedNCT01911546What this trial is testingRole of Everolimus in Highly Sensitized PatientsWho this might be right forHighly-sensitized Kidney Transplant Recipients Joseph Kahwaji, MD, MPH 20
Not applicableUnknownNCT03858907What this trial is testingCytomegalovirus Risk in Seropositive Kidney Transplant Recipients Stratified by Quantiferon-CMVWho this might be right forCytomegalovirus InfectionsCMVKidney Transplant Infection University of Sao Paulo General Hospital 180
Post-approval studies (Phase 4)Not Yet RecruitingNCT07571135What this trial is testingLetermovir vs Valganciclovir in CMV R+ Kidney TransplantWho this might be right forCMV InfectionCMVCMV Viremia+1 more Elisabeth Kincaide 300
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06971913What this trial is testingEfficacy and Safety of Low-dose IL-2 in SLE Patients With CMV ViremiaWho this might be right forSLE (Systemic Lupus)CMV Peking University People's Hospital 100
Not applicableLooking for participantsNCT06341543What this trial is testingQuantiferon CMV to Identify Treatment Need for Asymptomatic CMV Infection After Solid Organ Transplant (QUANTIFOT)Who this might be right forCytomegalovirus InfectionsHeart TransplantationKidney Transplantation+2 more University Hospital, Grenoble 288
Testing effectiveness (Phase 2)Looking for participantsNCT07383649What this trial is testingTrial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV InfectionWho this might be right forBrain Cancer MetastaticCMV Viremia The Methodist Hospital Research Institute 28
Testing effectiveness (Phase 2)Study completedNCT04018261What this trial is testingVirus-specific Activated T Lymphocytes From a Donor in Hematopoietic Progenitor Transplanted PatientsWho this might be right forCMV ViremiaImmunosuppression-related Infectious Disease Banc de Sang i Teixits 26
Not applicableUnknownNCT06263218What this trial is testingReal-world CMV Outcomes Among Kidney Transplant Recipients in BrazilWho this might be right forCMV InfectionCMV Viremia Hospital do Rim e Hipertensão 500
Not applicableStudy completedNCT02784756What this trial is testingCell-Mediated Immunity Based Primary Prophylaxis for CMV Infection in Organ Transplant RecipientsWho this might be right forCytomegalovirus Viraemia University Health Network, Toronto 134
Post-approval studies (Phase 4)Study completedNCT00431353What this trial is testingVICTOR Study - A Study of Valcyte (Valganciclovir po) Compared to Ganciclovir iv in Patients With Cytomegalovirus (CMV) Disease Who Are Solid Organ Transplant RecipientsWho this might be right forCytomegalovirus Infections Hoffmann-La Roche 325